The Global Antibiotic Research and Development Partnership (GARDP) and Evotec AG are today announcing the formation of a new strategic public-private partnership to tackle the growing threat of antimicrobial resistance.
GENEVA – The Global Antibiotic Research & Development Partnership (GARDP) and Penta, the paediatric infectious diseases research network, have joined forces to tackle drug-resistant infections … GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR
GENEVA AND BERLIN – The Global Antibiotic Research & Development Partnership (GARDP) is pleased to receive a EUR 1.5 million investment from the German Federal … German MOH continues supporting GARDP’s efforts to develop affordable antibiotics
GENEVA AND LIVERPOOL – The University of Liverpool has signed a collaborative research agreement with the Global Antibiotic Research and Development Partnership (GARDP) in a … Research collaboration agreement seeks to address deaths in newborns from sepsis
[日本語] TOKYO AND GENEVA – The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. (TSE: 4523) (“Eisai”) and Takeda Pharmaceutical Company Limited (TSE: … GARDP, Eisai and Takeda announce partnership in the search for new antibiotics
GENEVA AND BERLIN– The Global Antibiotic Research & Development Partnership (GARDP) is pleased to receive a EUR 50 million investment from the German Federal Ministry … German government funds GARDP’s efforts to discover, develop and deliver affordable antibiotics
GENEVA AND BASEL – The Global Antibiotic Research & Development Partnership (GARDP) and Novartis are joining forces to accelerate the development and availability of generic … GARDP and Novartis announce partnership to reduce child deaths from drug-resistant infections
GENEVA – The Global Antibiotic Research and Development Partnership (GARDP) is pleased to announce £1 million investment from the Wellcome Trust. This funding will contribute … Wellcome Trust funds GARDP’s efforts to develop and deliver antibiotics for drug-resistant infections
GENEVA AND LONDON – The Global Antibiotic Research and Development Partnership (GARDP) is pleased to announce a £1m investment from the UK Government’s Department of Health … GARDP’s efforts to address drug-resistant gonorrhoea treatment receive boost from UK government
GENEVA – The Global Antibiotic Research and Development Partnership (GARDP) is pleased to announce the strengthening of its collaborative efforts with the South African Medical … South African Medical Research Council funds GARDP efforts to deliver new antibiotics for drug-resistant infections